{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:39:25Z","timestamp":1762504765825,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1067\/mjd.2002.109255","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"S193-S195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S","title":["Thalidomide therapy for cicatricial pemphigoid"],"prefix":"10.1067","volume":"47","author":[{"given":"Daihung Jay","family":"Duong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Richard T.","family":"Moxley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Kellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie H.","family":"Pincus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony A.","family":"Gaspari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2002.109255_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0896-8411(91)90004-V","article-title":"Bullous and cicatricial pemphigoid","volume":"4","author":"Anhalt","year":"1991","journal-title":"J Autoimmun"},{"key":"10.1067\/mjd.2002.109255_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0190-9622(82)70014-3","article-title":"Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone","volume":"6","author":"Rogers","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.109255_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004397-199803840-00009","article-title":"Ocular cicatricial pemphigoid","volume":"38","author":"Holsclaw","year":"1998","journal-title":"Int Ophthalmol Clin"},{"key":"10.1067\/mjd.2002.109255_bib4","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1067\/mjd.2002.109255_bib5","first-page":"97","article-title":"Pemphigoid: bullous, gestational, and cicatricial","author":"Anhalt","year":"1993"},{"key":"10.1067\/mjd.2002.109255_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2133.1974.tb06383.x","article-title":"Azathioprine in the treatment of muco-cutaneous pemphigoid","volume":"90","author":"Dave","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.109255_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004397-199603610-00007","article-title":"Cicatricial pemphigoid: diagnosis and treatment","volume":"36","author":"Nguyen","year":"1996","journal-title":"Int Ophthalmol Clin"},{"key":"10.1067\/mjd.2002.109255_bib8","first-page":"9","article-title":"Thalidomide use in dermatology","volume":"4","author":"Ochonisky","year":"1994","journal-title":"Eur J Dermatol"},{"key":"10.1067\/mjd.2002.109255_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0306-9877(83)90009-9","article-title":"Thalidomide for autoimmune disease","volume":"10","author":"Hendler","year":"1983","journal-title":"Med Hypotheses"},{"key":"10.1067\/mjd.2002.109255_bib10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-4362.1984.tb05696.x","article-title":"Thalidomide therapy for inflammatory dermatoses","volume":"23","author":"Grosshans","year":"1984","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2002.109255_bib11","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.53.12.828","article-title":"Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Beh\u00e7et's disease: use of neurophysiological studies to detect thalidomide neuropathy","volume":"53","author":"Gardner-Medwin","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1067\/mjd.2002.109255_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archderm.1990.01670310085012","article-title":"Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis","volume":"126","author":"Revuz","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.109255_bib13","first-page":"131","article-title":"Thalidomide therapy: an open trial","volume":"24","author":"Naafs","year":"1985","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2002.109255_bib14","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJM196212062672305","article-title":"The saga of thalidomide","volume":"267","author":"Mellin","year":"1962","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.109255_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archderm.1994.01690010070009","article-title":"Thalidomide neuropathy incidence and clinicoelectrophysiologic findings in 42 patients","volume":"130","author":"Ochonisky","year":"1994","journal-title":"Arch Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202000774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202000774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:25:40Z","timestamp":1759267540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962202000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0190962202000774"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2002.109255","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thalidomide therapy for cicatricial pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mjd.2002.109255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}